肾内科

订阅

MedSci主页 / 所有栏目 / 肾内科

HIFU在尿毒症继发性甲状旁腺功能亢进中的治疗

2012-04-10 范振光 肾脏病与透析肾移植

HIFU高强度聚焦超声尿毒症甲状旁腺功能亢进
关注

    最近开发的为破坏甲状旁腺腺瘤的非侵入性的高强度聚焦超声（HIFU）技术可能对慢性肾脏疾病继发的甲状旁腺功能亢进（SHP）患者的治疗也是有益的。我们使用这种方法进行了试验研究。       研究者对5位慢性血液透析患者合并有严重的继发性甲状旁腺功能亢进，分别接受1至3次高强度聚焦超声治疗。接受这种治疗的患者均至少有一个或两个肿大的甲状旁腺

    最近开发的为破坏甲状旁腺腺瘤的非侵入性的高强度聚焦超声（HIFU）技术可能对慢性肾脏疾病继发的甲状旁腺功能亢进（SHP）患者的治疗也是有益的。我们使用这种方法进行了试验研究。       研究者对5位慢性血液透析患者合并有严重的继发性甲状旁腺功能亢进，分别接受1至3次高强度聚焦超声治疗。接受这种治疗的患者均至少有一个或两个肿大的甲状旁腺。   结果：从长远看，血清甲状旁腺激素（ iPTH）在1 -I和5–V患者中是降低的。3-N患者的血清甲状旁腺激素显著下降到正常范围，但随后又再次上升。在2-E和4-D患者中，血清甲状旁腺激素也暂时下降，但高强度聚焦超声并未能改善继发甲状旁腺功能亢进。5位患者中有4位血清总钙、磷暂时或长期下降。5位患者中有4位血清总碱性磷酸酶减少。副作用包括局部水肿，声带活动度和声音的暂时降低。       因此，高强度聚焦超声（HIFU）技术可能有助于慢性肾脏疾病继发的甲状旁腺功能亢进的治疗。同时也需要进一步的经验。

文献来源：http://www.medlive.cn/literature/31226

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-06-16 xzw113

    #继发性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-06-28 xuqianhua

    #HIFU#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2013-03-02 feifers

    #继发#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 tcm99hq

    #尿毒症#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 jmtang

    #甲状旁腺功能亢进#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 huperzia

    #甲状旁腺#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1952642, encodeId=8f02195264235, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 16 04:45:00 CST 2012, time=2012-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085131, encodeId=c3f02085131c3, content=<a href='/topic/show?id=77ad8830ec' target=_blank style='color:#2F92EE;'>#HIFU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8830, encryptionId=77ad8830ec, topicName=HIFU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Thu Jun 28 18:45:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724405, encodeId=45371e244055e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Sat Mar 02 22:45:00 CST 2013, time=2013-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290385, encodeId=5c0612903853f, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379532, encodeId=e44713e9532ee, content=<a href='/topic/show?id=82e369829c0' target=_blank style='color:#2F92EE;'>#甲状旁腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69829, encryptionId=82e369829c0, topicName=甲状旁腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b796455, createdName=jmtang, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452425, encodeId=7095145242523, content=<a href='/topic/show?id=d90469826e2' target=_blank style='color:#2F92EE;'>#甲状旁腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69826, encryptionId=d90469826e2, topicName=甲状旁腺)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84ba5566863, createdName=huperzia, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556013, encodeId=4a6a15560136d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Apr 12 12:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 wrj0126

    #HIF#

    0